Related Experiment Video
Updated: May 4, 2026
06:38
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
1.1K
CASP3 protein expression by flow cytometry in Down's syndrome subjects
Michele Salemi1, Rosita A Condorelli, Corrado Romano
1IRCCS Associazione Oasi Maria SS, Institute for Research On Mental Retardation and Brain Aging, Troina, EN, Italy, micezia@tiscali.it.
Human Cell
|December 17, 2013
Summary
Down's syndrome (DS) is linked to increased Caspase-3 (CASP3) protein levels. This suggests CASP3 may contribute to neurodegenerative processes in individuals with DS.
Area of Science:
- Genetics
- Neuroscience
- Cell Biology
Background:
- Down's syndrome (DS), caused by trisomy 21, is associated with intellectual disability and an increased risk of early-onset Alzheimer disease (AD) traits.
- Apoptosis, or programmed cell death, is crucial in development and disease.
- Caspase-3 (CASP3) is a key enzyme in apoptosis, implicated in neuronal death and elevated in AD models.
Purpose of the Study:
- To investigate the expression of Caspase-3 (CASP3) protein in fibroblasts from individuals with Down's syndrome (DS).
- To explore the potential role of CASP3 in the apoptotic pathways involved in neurodegeneration in DS.
Main Methods:
- Fibroblast cultures were established from individuals with DS and normal subjects.
- Flow cytometry was utilized to quantify CASP3 protein expression levels.
Main Results:
- Fibroblasts from individuals with DS exhibited significantly higher levels of CASP3 protein compared to controls.
- This up-regulation of CASP3 protein was observed in the DS fibroblast cultures.
Conclusions:
- The findings support the hypothesis that elevated CASP3 gene expression contributes to the activation of apoptotic pathways in Down's syndrome.
- Over-expression of CASP3 may play a role in the neurodegenerative processes observed in individuals with DS.
